Search for other papers by Giovanni Tulipano in
Google Scholar
PubMed
transcription regulators. Glucocorticoids modulate GH secretion by acting at the hypothalamic and pituitary level and can also influence downstream effectors like insulin-like growth factor-1 (IGF-1). For a long time, a model of biphasic dose-dependent effects
Search for other papers by Kylie D Rock in
Google Scholar
PubMed
Search for other papers by Brian Horman in
Google Scholar
PubMed
Search for other papers by Allison L Phillips in
Google Scholar
PubMed
Search for other papers by Susan L McRitchie in
Google Scholar
PubMed
Search for other papers by Scott Watson in
Google Scholar
PubMed
Search for other papers by Jocelin Deese-Spruill in
Google Scholar
PubMed
Bioinformatics Research Center, North Carolina State University, Raleigh, North Carolina, USA
Search for other papers by Dereje Jima in
Google Scholar
PubMed
Center for Human Health and the Environment, North Carolina State University, Raleigh, North Carolina, USA
Search for other papers by Susan Sumner in
Google Scholar
PubMed
Search for other papers by Heather M Stapleton in
Google Scholar
PubMed
Center for Human Health and the Environment, North Carolina State University, Raleigh, North Carolina, USA
Search for other papers by Heather B Patisaul in
Google Scholar
PubMed
) signaling ( Abcc2 ). A set of pre-identified genes of interest were also selected based on previous studies highlighting metabolic ( Lepr , Igf1 and Pparg ), thyroid ( Ttr ) and sex steroid signaling ( Esr1 and Ar ) pathways as potential targets of FM
Search for other papers by Brenda Anguiano in
Google Scholar
PubMed
Search for other papers by Carlos Montes de Oca in
Google Scholar
PubMed
Search for other papers by Evangelina Delgado-González in
Google Scholar
PubMed
Search for other papers by Carmen Aceves in
Google Scholar
PubMed
-adrenergic receptor levels. (70) 0.1 LNCaP Biphasic response. Increases the specific binding to GH and GH receptor expression within the first 24 h and reduces the binding at 72 h. (63) 0.1 LNCaP Increases gene expression of IGF-1, IGF
Search for other papers by Shruti Khare in
Google Scholar
PubMed
Search for other papers by Anurag R Lila in
Google Scholar
PubMed
Search for other papers by Hiren Patt in
Google Scholar
PubMed
Search for other papers by Chaitanya Yerawar in
Google Scholar
PubMed
Search for other papers by Manjunath Goroshi in
Google Scholar
PubMed
Search for other papers by Tushar Bandgar in
Google Scholar
PubMed
Search for other papers by Nalini S Shah in
Google Scholar
PubMed
evaluated for evidence of GH excess and whenever it was suspected, insulin-like growth factor 1 (IGF1) levels were done. Patients with raised IGF1 (thus with GH and prolactin co-secretion) were not included in the study. All hormonal measurements were
Search for other papers by Xi Wang in
Google Scholar
PubMed
Search for other papers by Qi Yu in
Google Scholar
PubMed
(pg/mL) (pre) E 2 (pg/mL) (on) AP (U/L) (pre) AP (U/L) (on) LH (IU/L) (pre) LH (IU/L) (on) FSH (IU/L) (pre) FSH (IU/L) (on) T (ng/mL) (pre) T (nmol/L) (on) IGF-1 (ng/mL) (pre) IGF-1 (ng/mL) (on) PRL (ng/mL) (pre) PRL (ng
Clinical Institute, University of Southern Denmark, Odense C, Denmark
Search for other papers by Morten Winkler Møller in
Google Scholar
PubMed
Department of Endocrinology, Odense University Hospital, Odense C, Denmark
Search for other papers by Marianne Skovsager Andersen in
Google Scholar
PubMed
Clinical Institute, University of Southern Denmark, Odense C, Denmark
Search for other papers by Christian Bonde Pedersen in
Google Scholar
PubMed
Department of Pathology, Odense University Hospital, Odense C, Denmark
Search for other papers by Bjarne Winther Kristensen in
Google Scholar
PubMed
Clinical Institute, University of Southern Denmark, Odense C, Denmark
Search for other papers by Frantz Rom Poulsen in
Google Scholar
PubMed
were discussed with senior neurosurgeons. Pituitary function Pituitary hormone evaluation was assessed preoperatively and postoperatively based on clinical biochemical data including the hypothalamic–pituitary–somatotropic axis (s-GH and s-IGF-1
Search for other papers by Vanderlan O Batista in
Google Scholar
PubMed
Search for other papers by Michael Kellner in
Google Scholar
PubMed
Search for other papers by Roberto Salvatori in
Google Scholar
PubMed
Search for other papers by Walter Lisboa in
Google Scholar
PubMed
Search for other papers by André Faro in
Google Scholar
PubMed
Search for other papers by Lucas B Santos in
Google Scholar
PubMed
Search for other papers by Enaldo V Melo in
Google Scholar
PubMed
Search for other papers by Alécia A Oliveira-Santos in
Google Scholar
PubMed
Search for other papers by Carla R P Oliveira in
Google Scholar
PubMed
Search for other papers by Viviane C Campos in
Google Scholar
PubMed
Search for other papers by Cynthia S Barros-Oliveira in
Google Scholar
PubMed
Search for other papers by Elenilde G Santos in
Google Scholar
PubMed
Search for other papers by Nathalie O Santana in
Google Scholar
PubMed
Search for other papers by Keila R Villar-Gouy in
Google Scholar
PubMed
Search for other papers by Ângela C Leal in
Google Scholar
PubMed
Search for other papers by Rivia S Amorim in
Google Scholar
PubMed
Search for other papers by Davi A Oliveira Simões in
Google Scholar
PubMed
Search for other papers by Manuel H Aguiar-Oliveira in
Google Scholar
PubMed
function, like immune and visual function, seems to depend more on extrapituitary circuits, namely insulin ( 4 , 5 ), IGF2 ( 6 ), brain GH ( 7 ), and brain IGF1 and IGF2 ( 8 , 9 ) than on the classical somatotropic axis (pituitary GH and circulating IGF1
Department of Pediatric Endocrinology, Wilhelmina Children’s Hospital, University Medical Center, Lundlaan, EA Utrecht, The Netherlands
Search for other papers by I M A A van Roessel in
Google Scholar
PubMed
Department of Pediatric Endocrinology, Wilhelmina Children’s Hospital, University Medical Center, Lundlaan, EA Utrecht, The Netherlands
Search for other papers by J E Gorter in
Google Scholar
PubMed
Department of Pediatric Endocrinology, Wilhelmina Children’s Hospital, University Medical Center, Lundlaan, EA Utrecht, The Netherlands
Search for other papers by B Bakker in
Google Scholar
PubMed
Wilhelmina Children’s Hospital, University Medical Center, Lundlaan, EA Utrecht, The Netherlands
Search for other papers by M M van den Heuvel-Eibrink in
Google Scholar
PubMed
Department of Radiology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands
Search for other papers by M H Lequin in
Google Scholar
PubMed
Search for other papers by J van der Lugt in
Google Scholar
PubMed
Search for other papers by L Meijer in
Google Scholar
PubMed
Search for other papers by A Y N Schouten-van Meeteren in
Google Scholar
PubMed
Department of Pediatric Endocrinology, Wilhelmina Children’s Hospital, University Medical Center, Lundlaan, EA Utrecht, The Netherlands
Search for other papers by H M van Santen in
Google Scholar
PubMed
thirst feeling 8.3% (3/36) 1.6% (1/63) 0.135 No pituitary deficiency 63.9% (23/36) 77.8% (49/63) 0.136 CPP 38.5% (10/26) 43.8% (21/48) 0.660 Elevated IGF-1 42.4% (14/33) 25.4% (15/59) 0.092 Overweight at
Search for other papers by Ling Hu in
Google Scholar
PubMed
Search for other papers by Ting Li in
Google Scholar
PubMed
Search for other papers by Xiao-Ling Yin in
Google Scholar
PubMed
Search for other papers by Yi Zou in
Google Scholar
PubMed
PC Koujak S Brown E Eyzaguirre A Tao N Rosenfeld-Franklin M Lerner L Chiu MI Wild R, et al . Compensatory insulin receptor (IR) activation on inhibition of insulin-like growth factor-1 receptor (IGF-1R): rationale
Search for other papers by Alicia Romano in
Google Scholar
PubMed
Search for other papers by Juan Pablo Kaski in
Google Scholar
PubMed
Search for other papers by Jovanna Dahlgren in
Google Scholar
PubMed
Search for other papers by Nicky Kelepouris in
Google Scholar
PubMed
Search for other papers by Alberto Pietropoli in
Google Scholar
PubMed
Search for other papers by Tilman R Rohrer in
Google Scholar
PubMed
Search for other papers by Michel Polak in
Google Scholar
PubMed
.31) 13 −2.57 (1.54) Bone age/chronological age 163 0.83 (0.19) 8 0.87 (0.10) IGF1 SDS (22) 162 −1.13 (1.62) 7 −1.22 (1.98) GH dose at baseline (mg/kg/day) 404 0.044 (0.014) 21 0.040 (0.019) GH-naïve at